SciBrunch Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SciBrunch Therapeutics - overview
Established
2024
Location
Shanghai, -, China
Primary Industry
Pharmaceuticals
About
Based in Shanghai, China and founded in 2024, Shanghai SciBrunch Therapeutics Co. , Ltd. , trading as SciBrunch Therapeutics, is a pharmaceutical technology company that provides small molecule antitumor drugs. In January 2026, SciBrunch Therapeutics raised over USD 35 million in Pre-Series A funding led by new investor HighLight Capital, with participation from new investors Suzhou Xincheng Private Equity Fund Management, returning investors Elikon Venture, LongRiver Investments, BioTrack Capital and Hankang Capital.
The company specializes in the iterative innovation of these drugs. The company uses a new perspective to identify clinically validated targets and proactively designs differentiated product performance to create a competitive product pipeline. The company generates revenue by doing R&D and providing small molecule anti-cancer drugs. The Pre-series A funding raised in January 2026 will be primarily used to accelerate the clinical development of its core pipeline SPR1020 and advance the IND development of a new generation of innovative molecular glue-type RAS inhibitors, explore the clinical potential in refractory tumors with RAS mutations (colorectal cancer, pancreatic cancer, non-small cell lung cancer, etc.
), and comprehensively empowering the creation of preferred treatment options for RAS-driven cancers.
Current Investors
BioTrack Capital, Hankang Capital, Elikon Venture
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.scibrunch.com
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.